Log In
BCIQ
Print this Print this
 

SMT-201

  Manage Alerts
Collapse Summary General Information
Company SteadyMed Ltd.
DescriptionCombination of SteadyMed's PatchPump technology and ketorolac, an NSAID
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationPain
Indication DetailsTreat post-surgical pain
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today